Most cancer types have no routine screening recommendation for average-risk patients, and by the time symptoms appear, opportunities for early intervention may already be limited. Join us for this webinar exploring how Early Cancer Risk Detection can become a practical part of your annual preventive care strategy. You’ll learn how OneTest™—a multi-cancer early detection test powered by FDA-approved biomarkers and an AI model trained on more than 27,000 individuals—helps clinicians move beyond disease detection and toward ongoing cancer risk monitoring, all within an existing wellness workflow through Evexia Diagnostics.
During this webinar, we’ll review the science behind OneTest™, how it differs from traditional screening methods, ctDNA testing, and standard blood panels, and how longitudinal biomarker tracking can help identify changing cancer risk over time. You’ll also learn how to identify appropriate patients, address common patient questions, compare OneTest™ Standard and Premium options, and confidently introduce Early Cancer Risk Detection as a routine component of prevention-focused care.
Speaker: Dr. Michael Lebowitz, Ph.D.
